MASLD is prevalent among adults and increasingly recognized in younger populations, emphasizing the need for age-specific reference values for fasting glucose-insulin metabolism to enhance risk stratification, especially in children with obesity (38–40). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.